BioAge Labs, Inc. - 8-K Filing
BioAge Labs reported Q1 2026 financial results with collaboration revenue of $2.8 million (up from $1.5 million in the same period last year) and a net loss of $22.3 million, or $0.52 per share. The company raised $132.3 million through an upsized follow-on public offering earlier this year and holds approximately $384.9 million in cash as of March 31, 2026. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $BIOA